Company intelligence / Profile preview
Reprogenix Bioscience
Hangzhou, Zhejiang, Chinareprogenix.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Reprogenix’s lead candidate, RGB5088, is a chemically-induced pluripotent stem cell-derived islet product that has demonstrated the first-ever achievement of insulin independence in type 1 diabetes patients following transplantation. In a published pilot clinical study, patients achieved insulin independence within 75 days post-transplantation with excellent glycemic control and no signs of malignancy. The product has received IND approval in China, Phase 1 trials are ongoing, and pivotal Phase 2/3 trials are planned to begin in 2026 with BLA filing targeted for late 2027
- Therapeutic areas
- Endocrinology
- Modalities
- Induced pluripotent stem cell derived therapyCell therapyGene editing
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Academic collaborations with Peking University Stem Cell Research CenterZhejiang Province "Leading Goose" R&D Project Plan
Beyond the preview
Go deeper on Reprogenix Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reprogenix Bioscience.